DiagnoSuite aims at developing an integrated and coherent suite of software tools that will allow our partner, Novigenix (former Diagnoplex), going from early research data to a fully-functioning diagnostic algorithm that complements the commercialized screening test. Three main processes are intended: biomarker selection, diagnostic algorithm development, and secure exploitation of this latter.